Astellas Pharma Inc (4503.T)
Japan's Astellas Pharma Inc and San Diego-based Vical Inc said their experimental herpes vaccine failed a mid-stage study involving certain kidney transplant patients.
* Results from study demonstrated that trial did not meet its primary endpoint
* Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "AA" - R&I
Pfizer Inc , beating out numerous other bidders, said it agreed to buy U.S. cancer drug company Medivation Inc for $14 billion in cash, adding its blockbuster prostate cancer drug Xtandi to the company's growing oncology roster. | Video
Aug 22 Pfizer Inc, beating out numerous other bidders, said it agreed to buy U.S. cancer drug company Medivation Inc for $14 billion in cash, adding its blockbuster prostate cancer drug Xtandi to the company's growing oncology roster.
BRIEF-Astellas Pharma submits new drug application for extended-release tablets of quetiapine fumarate in Japan
* Says it submitted a new drug application to the Ministry of Health, Labour and Welfare in Japan for extended-release tablets of quetiapine fumarate for the indication of improvement of depressive symptoms associated with bipolar disorder
* Proteostasis Therapeutics achieves preclinical milestone in Astellas Pharma collaboration
* Says its unit to sell Astellas Pharma Technologies, Inc. to Avara Norman Pharmaceutical Services, Inc (Avara) on Aug. 4 (U.S time)
* Astellas announces transfer of U.S. manufacturing subsidiary to Avara
* Will not update financial guidance until Q3 earnings due to recent expansion of collaboration with Astellas
Earnings vs. Estimates
Analyst Research Reports
Provider : Thomson Reuters Stock Report
Astellas Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider : Reuters Investment Profile
Provider : Pechala's Reports
Provider : Ford Investor Services, Inc.
"The Economy Matters" Report for ALPMY: the economy's impact on ALPMY's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score
Provider : MacroRisk Analytics/EconomicInvestor
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.